Innovating Works

BDF

Desconocido
Safe Gestation: Feasibility study for clinical validation of NTproCNP as a novel biomarker for pregnancy complicatio... THE ANTIBODY LAB GMBH tramitó un H2020: H2020-SMEInst-2014-2015 In Europe and US about 12 million women are pregnant every year. 2 % to 8 % are affected by pre-eclampsia and intra uterine growth restricti...
2015-06-03 - 2015-10-31 | Financiado
SYSKID: Systems biology towards novel chronic kidney disease diagnosis and treatment THE ANTIBODY LAB GMBH participó en un FP7: Chronic kidney disease (CKD) affects up to 10% of the population. Besides eventual progression towards end stage renal disease CKD impacts t...
Financiado
STELLAR: Stem cell based therapy for kidney repair THE ANTIBODY LAB GMBH participó en un FP7: Chronic kidney disease (CKD) affects 8% of the European population and ultimately results in renal failure due to progressive fibrosis. CDK...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.